Skip to content
Visnia
CtrlK
EconomyAI buildoutMarket MapFundsWatchlist
Log in
Market cap
Revenue
Net income
Cash on hand
Gross margin
Net margin
EPS
P/E ratio
Search
Market mapFundsWatchlist
Visnia

PPyxis Oncology, Inc.

EconomyAI buildoutMarket MapFundsWatchlist
Log in
P

Pyxis Oncology, Inc.

  • Overview
  • Financial statements
  • Metrics
  • Quarterly earnings
  • Similar companies
  • News
  • Insider Transactions
Loading insider transactions

Insider transactions

Insider sentiment

Insider transactions

Insider sentiment

SellBuy
DateNameTitleSharesValueTransactionSource
Oct 1, 2026GordonMD Global Investments LP10% Owner7,546,766Common Stock Purchase Warrant$25.3MBuy
Oct 1, 2026GordonMD Global Investments LP10% Owner5,517,000Common Stock, par value $0.001 per share ("Common Stock")$18.5MBuy
Sep 4, 2026Civik ThomasCEO & Chairman of the Board2,503,050Stock Option (Right to Buy)$9.7MGrant / award
Aug 20, 2026Dupont JakobDirector46,000Stock Option (Right to Buy)$138.5KGrant / award
Aug 12, 2026Civik ThomasInterim CEO250,956Stock Option (Right to Buy)$936.1KGrant / award
Jun 30, 2026Dupont JakobDirector35,000Common Stock$97KSell
Jun 30, 2026Dupont JakobDirector35,000Common Stock$97KOption exercise
Mar 24, 2026Palani SanthoshDirector45,867Stock Option (Right to Buy)$67.4KGrant / award
Mar 24, 2026HUMPHREY RACHELDirector45,867Stock Option (Right to Buy)$67.4KGrant / award
Mar 24, 2026Cline Darren SDirector45,867Stock Option (Right to Buy)$67.4KGrant / award
…
  • Overview
  • Financial statements
  • Metrics
  • Quarterly earnings
  • Burn Rate
  • Similar companies
  • News
  • Insider Transactions
$3.36Close · Sep 22, 2026